Skip to main content

Regular Dialysis Treatment (RDT)

  • Chapter
Replacement of Renal Function by Dialysis

Abstract

Today, throughout the world, close to 100,000 patients with end-stage renal disease are kept alive by maintenance hemodialysis therapy (1). As health care workers, it is incumbent upon us to be familiar with the many facets of this ubiquitous therapy. Important technical information such as selection of equipment for hemodialysis (dialyzers, monitors, etc.) is discussed elsewhere in this book. This chapter addresses the problems of when to initiate dialysis therapy, how to select a schedule, and special precautions and considerations for high risk patients. In addition to providing a scheme for routine monitoring of dialysis patients it also gives an assessment of 10 (or more) years veterans of dialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maher JF: Dialysis. In: Contemporary Nephrology, edited by Klahr S, Massry SG, Plenum Publishing Corporation, vol 1, 1981, p 579

    Google Scholar 

  2. Bonomini V, Albertazzi A, Vangelista A, Botorotti GS, Stefoni A and Scolari MP: Residual renal function and effective rehabilitation in chronic dialysis. Nephron 16: 89, 1976

    Article  PubMed  CAS  Google Scholar 

  3. Bonomini V: On optimal dialysis. Kidney Int 7 (Suppl 3): S365, 1975

    Google Scholar 

  4. Bonomini V: Long term early dialysis. 3rd International Conference Uremia Capri (Abstracts) 7, 1980

    Google Scholar 

  5. Scribner BH: A critical comment. Nephron 16: 100, 1976

    Article  Google Scholar 

  6. Berlyne GM, Giovannetti S: When should entry into a regular hemodialysis program occur? Nephron 16: 81, 1976

    Article  PubMed  CAS  Google Scholar 

  7. Maher JF: When should maintenance dialysis be initiated? Nephron 16: 83, 1976

    Article  PubMed  CAS  Google Scholar 

  8. Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Eng J Med 275: 1089, 1966

    Article  CAS  Google Scholar 

  9. Butt KMH, Rao TKS, Maki T, Mashimo S, Manis T, Delano BG, Kountz SL, Friedman EA: Bovine heterograft as a preferential hemodialysis access. Trans Am Soc Artif Intern Organs 20: 339, 1974

    Google Scholar 

  10. Ahearn DJ, Maher JF: Heart failure as a complication of hemodialysis arteriovenous fistula. Ann Intern Med 77: 201, 1972

    PubMed  CAS  Google Scholar 

  11. Bergrem H, Flatmark A, Simonsen S: Dialysis fistulas and cardiac failure. Acta Med Scand 204: 191, 1978

    Article  PubMed  CAS  Google Scholar 

  12. Maher JF, Ahearn DJ, Bryan CW, Nolph KD: Prognosis of chronic renal failure — III Survival after one peritoneal dialysis. Nephron 15: 8, 1975

    Article  PubMed  CAS  Google Scholar 

  13. Erben J, Kvanicka J, Bastecky J, Vortel V: Experience with routine use of subclavian vein cannulation in haemodialysis. Proc Eur Dial Tranpl Assoc 6: 59, 1969

    Google Scholar 

  14. Arana VA: Percutaneous femoral vein catheterization in patients requiring hemodialysis. J Urol 106: 492, 1971

    PubMed  CAS  Google Scholar 

  15. Shaldon S, Silva H, Pomeroy J, Rao AI, Rosen SM: Percutaneous femoral venous catheterization and reusable dialyzer in the treatment of acute renal failure. Trans Am Soc Artif Intern Organs 10: 133, 1964

    PubMed  CAS  Google Scholar 

  16. Pascua LJ: Vascular access update. Trans Am Soc Artif Intern Organs 25: 526, 1979

    PubMed  Google Scholar 

  17. Matalon R, Nidus BD, Cantacuzino D, Eisinger RP: Intermittent hemodialysis with repeated femoral vein puncture. JAMA 214: 1883, 1970

    Article  PubMed  CAS  Google Scholar 

  18. DoCampo DM, Rao TKS, Butt KMH, Friedman EA: Nurse performed percutaneous femoral vein catheterizations for hemodialysis. Abstracts Southeastern Dial Transpl Assoc 11: 35, 1976

    Google Scholar 

  19. Kjellstrand CM, Merino GE, Mauer SM, Casai R, Buselmeier TJ: Complications of percutaneous femoral vein catheterization for hemodialysis. Clin Nephrol 4: 37, 1975

    PubMed  CAS  Google Scholar 

  20. Uldall PR, Dyck RF, Woods F, Merchant N, Martin GS, Cardella CJ, Sutton D, DeVeber G A: A subclavian cannula for temporary vascular access for hemodialysis or plasmapheresis. Dial Transpl 8: 963, 1979

    Google Scholar 

  21. Maxey RW, Rao TKS, Manis T, Delano BG, Friedman EA: Return of renal function after commencing maintenance hemodialysis. Proc Clin Dial Transpl Forum 5: 12, 1975

    CAS  Google Scholar 

  22. Mamdani BH, Lim VS, Mahurkar SD, Katz AI, Dunea G: Recovery from prolonged renal failure in patients with accelerated hypertension. N Engl J Med 291: 1343, 1974

    Article  PubMed  CAS  Google Scholar 

  23. Siegel EG: Recovery from anuria due to malignant hypertension. JAMA 215: 1122, 1971

    Article  PubMed  Google Scholar 

  24. Luft FC, Bloch R, Szwed JJ, Grim CM, Grim CE: Minoxidil treatment of malignant hypertension. Recovery of renal function. JAMA 240: 1985, 1978

    Google Scholar 

  25. Bacon BR, Ricanati ES: Severe and prolonged renal insufficiency. Reversal in a patient with malignant hypertension. JAMA 239: 1159, 1978

    Article  PubMed  CAS  Google Scholar 

  26. Mitchell HC, Graham RM, Pettinger WA: Renal function during long term treatment of hypertension with minoxidil. Ann Intern Med 93: 676, 1980

    PubMed  CAS  Google Scholar 

  27. Lam M, Ricanati ES, Kusher I: Reversal of severe renal failure in systemic sclerosis. Ann Intern Med 89: 642, 1978

    PubMed  CAS  Google Scholar 

  28. Mitnick PD, Feig PU: Control of hypertension and reversal of renal failure in scleroderma. N Engl J Med 299:871,

    Google Scholar 

  29. Graham MB, Kyser FA, Gashti EN: Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature. Am J Med 67: 533, 1979

    Article  PubMed  Google Scholar 

  30. Brown WW, Hebert LA, Piering WF, Pisciotta AVJ, Jr., Garancis JC: Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med 90: 793, 1979

    PubMed  CAS  Google Scholar 

  31. Anonymous: Ethics and the nephrologist. Editorial. Lancet 1: 594, 1981

    Google Scholar 

  32. Beauchamp TL: Can we stop or withhold dialysis? In: Controversies in Nephrology, edited by Schreiner GE, Washihgton, Georgetown Univ., 1979, p 164

    Google Scholar 

  33. Diamond LH: Can we stop or withhold dialysis? In: Controversies in Nephrology, edited by Schreiner GE, Washington, Georgetown Univ, 1979, p 171

    Google Scholar 

  34. Kennedy AC, Linton AL, Eaton JC: Urea levels in cerebrospinal fluid after haemodialysis. Lancet 1: 410, 1962

    Article  PubMed  CAS  Google Scholar 

  35. Rosen SM, O’Connor K, Shaldon S: Haemodialysis disequilibrium. Br Med J 2: 672, 1964

    Article  PubMed  CAS  Google Scholar 

  36. Hampers CL, Doak PB, Callaghan MN, Tyler HR, Merrill JP: The electroencephalogram and spinal fluid during hemodialysis, I. Arch Intern Med 118: 340, 1966

    Article  PubMed  CAS  Google Scholar 

  37. Arieff A: Neurological complications of uremia. In: The Kidney, edited by Brenner BM, Rector FC. Philadelphia, WB Saunders, Co, 1981, p 2325

    Google Scholar 

  38. Arieff AI, Massry SG, Barrientos A, Kleeman CR: Brain, water, and electrolyte metabolism in uremia: Effects of slow and rapid hemodialysis. Kidney Int 4: 177, 1973

    Article  PubMed  CAS  Google Scholar 

  39. Riggs GA, Bereu BA: Hypoglycemia. A complication of hemodialysis. N Engl J Med 277: 1139, 1967

    Article  Google Scholar 

  40. Wakim KG: Predominance of hyponatremia over hypoosmolality in simulation of the dialysis disequilibrium syndrome. Mayo Clin Proc 44: 433, 1969

    PubMed  CAS  Google Scholar 

  41. Co wie J, Lambie AT, Robson JS: The influence of extracorporeal dialysis on the acid base composition of blood and cerebrospinal fluid. Clin Sci 23: 397, 1962

    PubMed  CAS  Google Scholar 

  42. Arieff AI, Massry SG: Dialysis disequilibrium syndrome. In Clinical Aspects of Uremia and Dialysis, edited by Massry SG, Sellers AL, Springfield II, CC Thomas, 1976, p 36

    Google Scholar 

  43. Arieff AI, Guisado R, Massry SG, Lazarowitz VC: Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 58: 306, 1976

    Article  PubMed  CAS  Google Scholar 

  44. Bito LZ, Myers RE: On the physiological response of the cerebral cortex to acute stress. J Physiol (Lond) 221: 349, 1972

    CAS  Google Scholar 

  45. Maher JF, Schreiner GE: Hazards and complications of dialysis. N Engl J Med 273: 370, 1965

    Article  PubMed  CAS  Google Scholar 

  46. Porte FK, Johnson WJ, Klass OW: Prevention of dialysis disequilibrium syndrome by the use of high sodium concentration in the dialysate. Kidney Int 3: 327, 1973

    Article  Google Scholar 

  47. Rodrigo F, Shideman J, McHuch R, Buselmeier T, Kjellstrand C: Osmolality changes during hemodialysis. Ann Intern Med 86: 554, 1977

    PubMed  CAS  Google Scholar 

  48. Graefe U, Milutinovic J, Follette W, Vizzo J, Babb AL, Schribner BH: Less dialysis-induced morbidity and vascular instability with bicarbonate dialysis. Ann Intern Med 88: 332, 1978

    PubMed  CAS  Google Scholar 

  49. Rosen RA, Lazarowitz VC, Arieff AI: Dialysis disequilibrium syndrome prevention with glycerol. Kidney Int 14: 683, 1978

    Google Scholar 

  50. Gotch F: (Adequacy of dialysis). Introduction: structure of the conference. Kidney Int 7 (Suppl 2):S2, 1975

    Google Scholar 

  51. Lowrie EG, Lazarus JM, Hampers CL, Merrill JP: Some statistical methods for use in assessing the adequacy of hemodialysis. Kidney Int 7 (Suppl 2):S 231, 1975

    Google Scholar 

  52. Babb Al, Scribner BH: Quantitative description of dialysis treatment. I: A dialysis Index. Kidney Int 7 (Suppl 2): S23, 1975

    Google Scholar 

  53. Ahmad S, Babb AL, Milutinovic J, Scribner BH: Effect of residual renal function on minimal dialysis requirements. Proc Eur Dial Transpl Assoc 16: 107, 1979

    CAS  Google Scholar 

  54. Teschan PE: EEG and other neurophysiological abnormalities in the uremic syndrome. Kidney Int 7 (Suppl 2): S30, 1975

    Google Scholar 

  55. Funck-Brentano JL, Man NK, Sausse A: The effects of dialysis with PAN membrane on neuropathy and middle molecular weight toxins. Kidney Int 7 (Suppl 2): S 52, 1975

    Google Scholar 

  56. Hattler BG: The elusive middle molecule? Proc Clin Dial Transpl Forum 3: 130, 1973

    Google Scholar 

  57. Man NK, Granger A, Rondon- Nurete M, Zingraff J, Jungers P, Sausse A, Funck-Brentano JL: One year follow-up of short dialysis with a membrane highly permeable to the middle molecule. Proc Eur Dial Transpl Assoc 10: 236, 1973

    CAS  Google Scholar 

  58. Kjellstrand CM, Peterson RJ, Evans RL, Shideman JR, Von Hartitzsch B, Buselmeier TJ: Considerations of the middle molecule hypothesis II: neuropathy in nephrectomized patients. Trans Am Soc Artif Intern Organs 19: 325, 1973

    PubMed  CAS  Google Scholar 

  59. Bosl R, Shideman JR, Meyer RM, Buselmeier TJ, Von Hartitzsch B, Kjellstrand CM: Effects and complications of high efficiency dialysis. Nephron 15: 151, 1975

    Article  PubMed  CAS  Google Scholar 

  60. Gotch FA, Sargent JA, Peters JH: Studies on the molecular etiology of uremia. Kidney Int 7 (Suppl 2): S176, 1975

    Google Scholar 

  61. Asaba H, Bergström J, Fürst P, Oulès R, Zimmerman L: Accumulation and excretion of middle molecules. Proc Eur Dial Transpl Assoc 13: 481, 1976

    Google Scholar 

  62. Lowrie EG, Steinberg S, Galen MA, Gagneux SA, Lazarus JM, Gottlieb MN, Merrill JP: Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Kidney Int 10: 409, 1976

    Article  PubMed  CAS  Google Scholar 

  63. Kopple JD, Swendseid ME: Protein and amino acid metabolism in uremia patients undergoing maintenance hemodialysis. Kidney Int 7 (Suppl 2): S64, 1975

    Google Scholar 

  64. Desforges JR: A review of the effects of hemodialysis on the blood in uremia. Kidney Int 7 (Suppl 2): S 123, 1975

    Google Scholar 

  65. Parker TF: Study of transmembrane potential as an assessment of the adequacy of dialysis. Proc 12th Annu Contractors Conf Art if Kidney Progam, NIAMDD, edited by Mackey BB, NIH Publ No 81–1979, 1981, p 226

    Google Scholar 

  66. Slatopolsky E: Recommendations for treatment of renal osteodystrophy in dialysis patient. Kidney Int 7 (Suppl 2): S253, 1975

    Google Scholar 

  67. Lazarus JM, Lowrie EG, Hampers CL Merrill JP: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 7 (Suppl 2):S 167, 1975

    Google Scholar 

  68. DelGreco F, Simon NM, Davies W: Hypertension in chronic renal failure. The role of sodium volume homeostasis and the renal pressor system. Kidney Int 7 (Suppl 2):S 176, 1975

    Google Scholar 

  69. Feldman JN, Lundin AP, Delano BG, Friedman EA: Determination of adequate maintenance hemodialysis in clinical judgement. Abstracts Am Soc Artif Intern Organs 10: 42, 1981

    Google Scholar 

  70. DePalma JR: Adequate hemodialysis schedule. N Engl J Med 285: 353, 1972

    Google Scholar 

  71. Colton CK, Lowrie EG: Hemodialysis: Physical principles and technical considerations. In The Kidney edited by Brenner BM, Rector FC, Philadelphia PA, WB Saunders Co, 1981, p 2425

    Google Scholar 

  72. Seidman MS, Lundin AP, Brown CD, Friedman EA, Berlyne GM: Extent of blood recirculation during two needle hemodialysis. Abstracts Am Soc Artif Intern Organs 8: 56, 1979

    Google Scholar 

  73. Milutinovic J, Strand M, Casaretto A, Follette W, Babb AL, Scribner BH: Clinical impact of residual glomerular filtration rate on dialysis time. A preliminary report. Trans Am Soc Artif Intern Organs 20: 410, 1974

    PubMed  Google Scholar 

  74. Manji T, Maeda K, Ohta K, Saito A, Amano A, Kawaguchi S, Kobayashi K: Short time dialysis. Proc Eur Dial Transpl Assoc 12: 589, 1975

    Google Scholar 

  75. Alvarez-Ude F, Ward M, Elliot RW, Uldall PR, Wilkinson R, Appelton DR, Kerr DNS, Petrella E, Gentile M, Romagnoni M, Orlandini G, Luciani L, Ferrandes C, D’Amico G: A comparison of short and long haemodialysis. Proc Eur Dial Transpl Assoc 12: 606, 1975

    Google Scholar 

  76. Knoll O, Loew H, Graefe U, Steinhausen D, Langer K, Alterhoff G: Neuropathy and short time haemodialysis. Proc Eur Dial Transpl Assoc 16: 729, 1979

    Google Scholar 

  77. Ari BJ, Oren A, Berlyne GM: Short duration — high area regular dialysis using 2 UF coils in series. Nephron 16: 74, 1976

    Article  PubMed  CAS  Google Scholar 

  78. Frost TH, Kerr DNS: Kinetics of hemodialysis: A theoretical study of the removal of solutes in chronic renal failure compared to normal health. Kidney Int 12: 41, 1980

    Article  Google Scholar 

  79. Martin AM, Oduro-Domirah A, Gibbins JK, Devapal D, Mitchell DC: Regular short haemodialysis in end stage renal failure. Br Med J 3: 758, 1975

    Article  PubMed  CAS  Google Scholar 

  80. Lowrie EG, Laird NM, Parker TF, Sargent JA: The effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176, 1981

    Article  PubMed  CAS  Google Scholar 

  81. Funck-Brentano JL, Man NK, Sausse A: The effect of more porous dialysis membrane on neuropathic toxins. Kidney Int 7 (Suppl 3): S552, 1975

    Google Scholar 

  82. Sellars L, Robson V, Wilkinson R: Sodium retention and hypertension with short dialysis. Br Med J 1: 520, 1979

    Article  PubMed  CAS  Google Scholar 

  83. Cambi V: Critical appraisal of hemofiltration and ultrafiltration. The development of ultra short dialysis. Preliminary results. J Dial 2: 143, 1978

    PubMed  CAS  Google Scholar 

  84. Delano BG, Goodwin NJ: Patient transfer from center to home hemodialysis. Abstracts Am Soc Nephrol 4: 19, 1970

    Google Scholar 

  85. Dyck PJ, Johnson WJ, Lambert EH, Nelson RA, O’Brien RC: Uremic neuropathy-controlled study of restricted protein and fluid diet and infrequent hemodialysis versus conventional hemodialysis treatment. Mayo Clinic Proc 50: 641, 1975

    CAS  Google Scholar 

  86. Friedman EA, Saltzman MJ, Delano BG, Frank WM, Hirsch SR, Beyer MM, Galonsky RS: Clinical efficacy of oxidized starch in uremia. Proc 10th Annu Contractors’ Conf Chronic Uremia Program of NIAMDD, edited by Mackey BB, DHEW Publ no (NIH) 77–1442, 1977, p 112

    Google Scholar 

  87. Snyder D, Louis BM, Gorfien P, Mordujovich J: Clinical experience with long term brief ‘daily’ haemodialysis. Proc Eur Dial Transpl Assoc 11: 128, 1974

    Google Scholar 

  88. Manohar ND, Louis BM, Gorfien P, Lipner HI: Success of frequent short hemodialysis. Trans Am Soc Artif Intern Organs 27: 604, 1981

    PubMed  CAS  Google Scholar 

  89. Kjellstrand CM, Evans RL, Peterson RJ, Shideman JR, Von Hartitzsch B, Buselmeier TJ: The 4 unphysiology ‘of dialysis’: A major cause of dialysis side effects? Kidney Int 7 (Suppl 2): S 30, 1975

    Google Scholar 

  90. Briefel GR, Hutchisson JT, Galonsky RS, Hessert RL, Friedman EA: Compact travel hemodialysis system. Proc Clin Dial Transpl Forum 5: 61, 1975

    CAS  Google Scholar 

  91. Lindner A, Douglas SW, Adamson JW: Propranolol effects in long term hemodialysis patients with renin-depen- dent hypertension. Ann Intern Med 88: 457, 1978

    PubMed  CAS  Google Scholar 

  92. Fadem SZ, Lifschitz MD: Use of saralasin in end stage renal disease. Kidney Int 15 (Suppl 9): S 93, 1979

    Google Scholar 

  93. Peraino RA, Price CG: Efficacy of Clonidine in patients treated with hemodialysis. Proc Clin Dial Transpl Forum 8: 106, 1978

    CAS  Google Scholar 

  94. Maggiore Q, Biagini M, Zoccali C, Misefari M: Propranolol treatment of resistant arterial hypertension in patients on chronic haemodialysis. Proc Eur Dial Transpl Assoc 11: 222, 1974

    Google Scholar 

  95. Smith EC, Dhar MD, Freedman P: Propranolol in management of hypertension in long term dialysis programs. JAMA 299: 1777, 1974

    Article  Google Scholar 

  96. DeFremont JF, Coevoet B, Andrejak M, Makdassi R, Quichaud J, Lambrey G, Guéris J, Caillens C, Harichaux P, Alexandre JM, Fournier A: Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin, and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: Comparison of metoprolol, alphamethyldopa and Clonidine in a crossover trial. Clin Nephrol 12: 198, 1979

    CAS  Google Scholar 

  97. Henderson LW, Sanfelippo ML, Stone RA: Hemofiltration for long-term maintenance of patients with end stage renal disease: Impact of hypertension. Adv Nephrol 9: 21, 1980

    CAS  Google Scholar 

  98. Henderson LW: Hemofiltration for the treatment of hypertension associated with end-stage renal failure. Artif Organs 4: 103, 1980

    Article  PubMed  CAS  Google Scholar 

  99. Quellhorst E, Schuenemann B, Doht B: Treatment of severe hypertension in chronic renal failure by haemofiltration. Proc Eur Dial Transpl Assoc 14: 129, 1977

    CAS  Google Scholar 

  100. Bennett WM, Golper TA, Muther RS, McCarron DA: Efficacy of minoxidil in treatment of severe hypertension in systemic disorders. J Cardiovasc Pharmacol 2 (Suppl 2): S 142, 1980

    Google Scholar 

  101. Campese VM, Stein D, DeQuattro V: Treatment of severe hypertension with minoxidil: Advantages and limitations. J Clin Pharmacol 19: 231, 1979

    PubMed  CAS  Google Scholar 

  102. Mitchell HC, Pettinger WA: Long-term treatment of refractory hypertensive patients with minoxidil. JAMA 239: 2131, 1978

    Article  PubMed  CAS  Google Scholar 

  103. Wauters JP, Waeber B, Brunner HR, Turini GA, Guignard JP, Gavras H: Captopril and salt subtraction to treat ‘uncontrollable’ hypertension in haemodialysis patients. Proc Eur Dial Transpl Assoc 16: 610, 1979

    CAS  Google Scholar 

  104. Mimran A, Shaldon S, Barjon P, Mion C: The effect of an angiotensin antagonist (Saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Clin Nephrol 9: 63, 1978

    PubMed  CAS  Google Scholar 

  105. Ferguson RK, Vlasses PH, Kopiin JR, Shirinian A, Burke JF, Alexander JC: Captopril in severe treatment resistant hypertension. Am Heart J 99: 579, 1980

    Article  PubMed  CAS  Google Scholar 

  106. Lee C, Neff MS, Slifkin RF, Leiter E: Bilateral nephrectomy for hypertension in patients with chronic renal failure on a dialysis program. J Urol 119: 20, 1978

    PubMed  CAS  Google Scholar 

  107. Onesti G, Swartz C, Ramirez U: Bilateral nephrectomy for control of hypertension. Trans Am Soc Artif Intern Organs 14: 361, 1968

    PubMed  CAS  Google Scholar 

  108. Briggs WA: Nephrectomy in selected patients with severe refractory hypertension receiving dialysis. Surg Gynecol Obstet 141: 251, 1975

    PubMed  CAS  Google Scholar 

  109. Hull AR, Long DL, Prati RC, Pettinger WA, Parker TF: The control of hypertension in patients undergoing regular maintenance hemodialysis Kidney Int 7 (Suppl 2) S 184, 1975

    Google Scholar 

  110. Chester AC, Schreiner GE: Hypertension and hemodialysis. Trans Am Soc Artif Intern Organs 24: 36, 1978

    PubMed  CAS  Google Scholar 

  111. Zucchelli P, Auccala A, Santoro A, Sturani A, Esposti ED, Ligabue A, Chiarini C: Management of hypertension in dialysis. Int J Artif Organs 3: 79, 1980

    Google Scholar 

  112. Kornerup HJ, Fredstad B, Pedersen RS: A longitudinal study of arterial blood pressure in chronic haemodialysis patients with different levels of plasma renin concentration. Scand J Urol Nephrol 12: 161, 1978

    Article  PubMed  CAS  Google Scholar 

  113. Giordano C, De Santo NG, Rinaldi S, Acone D, Esposito R, Gallo B: Histidine for the treatment of uraemic anaemia. Br Med J 4: 114, 1973

    Article  Google Scholar 

  114. Bastron MD, Woods HF, Walls J: Persistant anemia associated with reduced serum B12 levels in patients undergoing regular hemodialysis therapy. Clin Nephrol 11: 133, 1979

    Google Scholar 

  115. Parker PA, Izard MW, Maher JF: Therapy of iron deficiency anemia in patients on maintenance hemodialysis. Nephron 23: 181, 1979

    Article  PubMed  CAS  Google Scholar 

  116. Williams JS, Stein JH, Ferris TF: Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study. Arch Intern Med 134: 289, 1974

    Article  PubMed  CAS  Google Scholar 

  117. Hendler ED, Goffinet JA, Ross S, Longnecker RD, and Bakoric V: Controled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 291: 1046, 1974

    Article  PubMed  CAS  Google Scholar 

  118. Mirahmadi MK, Vaziri ND, Gorman JT: Controlled evaluation of hemodialysis patients on nandrolone decanoate vs testosterone enanthate. Trans Am Soc Artif Intern Organs 25: 449, 1979

    PubMed  CAS  Google Scholar 

  119. Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N: A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304: 871, 1981

    Article  PubMed  CAS  Google Scholar 

  120. Zingraff J, Drueke T, Marie P, Man NK, Jungers P, Bordier P: Anemia and secondary hyperparathyroidism. Arch Intern Med 138: 1650, 1978

    Article  PubMed  CAS  Google Scholar 

  121. Barbour GL: Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 139: 889, 1979

    Article  PubMed  CAS  Google Scholar 

  122. Castellani A, Cristinelli L, Mileti M, Brandi S, Mombelloni G, Mioni G, Gregorini R, Maiorca PU, Guerra G, Maira L: Beneficial and determined effects of hemodialysis in uremic anemia. Kidney Int 11: 142, 1977

    Google Scholar 

  123. Erslev AJ: Anemia of chronic renal diseases. Arch Intern Med 128: 774, 1970

    Article  Google Scholar 

  124. Kumar S, Lesch M: Pericarditis in renal disease: Prog Cardiovasc Dis 22: 387, 1980

    Article  Google Scholar 

  125. Renfrew R, Buselmeier TJ, Kjellstrand CM: Pericarditis and renal failure. Annu Rev Med 31: 345, 1980

    Article  PubMed  CAS  Google Scholar 

  126. Horton JD, Gelfand MC, Sherber HS: Natural history of asymptomatic pericardial effusions in patients on maintenance hemodialysis. Proc Clin Dial Transpl Forum 7: 76, 1977

    CAS  Google Scholar 

  127. Kleiman JH, Motta J, London E, Penneil JP, Popp RL: Pericardial effusions in patients with end-stage renal disease. Br Heart J 40: 190, 1978

    Article  PubMed  CAS  Google Scholar 

  128. Osanldo E, Shalhoub RJ, Cioffi RF, Parker RH: Viral pericarditis in patients receiving hemodialysis. Arch Intern Med 139: 301, 1979

    Article  Google Scholar 

  129. Goldstein DH, Nagar C, Srivastava N, Schacht RA, Ferris FZ, Flowers NC: Clinically silent pericardial effusions in patients on long term hemodialysis. Pericardial effusions in hemodialysis. Chest 72: 744, 1977

    Article  PubMed  CAS  Google Scholar 

  130. Feigenbaum H: Echocardiography. Philadelphia PA, Lea amp; Febiger 1976, p 419

    Google Scholar 

  131. Gilman JK, Luft FC, Weyman AE: Echocardiography in the diagnosis of pericarditis in patients with uremia. Proc Clin Dial Transpl Forum 8: 121, 1978

    CAS  Google Scholar 

  132. Marin PV, Hull AR: Uremic pericarditis. A review of incidence and management. Kidney Int 7 (Suppl 2) S 163, 1975

    Google Scholar 

  133. Kwasnik EM, Koster K, Lazarus JM, Sloss LJ, Mee RB, Cohn L, Collins JJ: Conservative management of uremic pericardial effusions. J Thorac Cardiovasc Surg 76: 629, 1978

    PubMed  CAS  Google Scholar 

  134. El-Said W, Gabal IA: Treatment of uremic pericarditis and pericardial effusion by augmented hemodialysis. Int Urol Nephrol 10: 53, 1978

    Article  PubMed  CAS  Google Scholar 

  135. Swartz RD, Port FK: Preventing hemorrhage in high-risk hemodialysis. Regional versus low-dose heparin. Kidney Int 16: 513, 1979

    Article  PubMed  CAS  Google Scholar 

  136. Minuth ANW, Nottebohm GA, Eknoyan G, Suki NW: Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med 135: 807, 1975

    Article  PubMed  CAS  Google Scholar 

  137. Buselmeier TJ, Davin TD, Simmons RL, Hull AR, White MG, Duncan DA, Lynch RE, Mauer SM, Casali R, Sutherland DE, Howard RH, Najarian JS, Kjellstrand CM: Local steroid instillation versus pericardiectomy for intractable pericardial effusion: the problem revisited through a multi-institutional study. Trans Am Soc Artif Intern Organs 23: 719, 1977

    PubMed  CAS  Google Scholar 

  138. Buselmeier TJ, Davin TD, Simmons RL, Najarian JS, Kjellstrand CM: Treatment of intractable uremic pericardial effusion. Avoidance of pericardiectomy with local steroid instillation. JAMA 240: 1358, 1978

    Article  PubMed  CAS  Google Scholar 

  139. Lornoy W, DeBroe M, Hilderson J, Boghaert A, Cuvelier J, Derom F, Ringoir S: Uremic pericarditis in chronic hemodialysis patients. Treatment by surgical pericardiostomy. Acta Clin Belg 32: 230, 1977

    PubMed  CAS  Google Scholar 

  140. Schott CR, LeSar JF, Kotler MN, Parry WR, Segal BL: The spectrum of echocardiography findings in chronic renal failure. Cardiovasc Med 3: 217, 1978

    Google Scholar 

  141. Acquatella H, Perez-Rojas M, Burger B: Left ventricular function in terminal uremia. A hemodynamic and echocardiographic study. Nephron 22: 160, 1978

    Article  PubMed  CAS  Google Scholar 

  142. Sherrard DJ, Brunzell JD: Uremic hyperlipidemia: The nature of the problem. Proc Clin Dial Transpl Forum 7: 176, 1977

    CAS  Google Scholar 

  143. Rapoport J, Aviram M, Chaimovitz C, Brook JG: Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis. N Engl J Med 299: 1326, 1978

    Article  PubMed  CAS  Google Scholar 

  144. Davidson RC, Pendras JR: Calcium related cardiorespiratory deaths in chronic hemodialysis. Trans Am Soc Art if Intern Organs 13: 36, 1967

    Google Scholar 

  145. Delano BG, Nacht R, Friedman EA, Krasnow N: Myocardial anaerobiosis in anemia in uremic man. Am J Cardiol 29: 39, 1972

    Article  PubMed  CAS  Google Scholar 

  146. Neff MS, Kim KE, Persoff M, Onesti G, Swartz C: Hemodynamics of uremic anemia. Circulation 43: 876, 1971

    PubMed  CAS  Google Scholar 

  147. Cerra FB, Shapiro R, Anthone R, Anthone S: Physiologic response patterns to occlusion of clinically significant arteriovenous fistulas. J Dial 1: 665, 1977

    PubMed  CAS  Google Scholar 

  148. Anderson CB: Cardiac failure and upper extremity arteriovenous dialysis fistula. Arch Intern Med 136: 292, 1976

    Article  PubMed  CAS  Google Scholar 

  149. Hung J, Harris PJ, Uren RF, Tiller DJ, Kelly DT: Uremic cardiomyopathy-effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med 302: 547, 1980

    Article  PubMed  CAS  Google Scholar 

  150. Friedman HS: Effect of hemodialysis on left ventricular function in uremic cardiomyopathy. N Engl J Med 303: 524, 1980

    Article  PubMed  CAS  Google Scholar 

  151. Scharf S, Wexler J, Longnecker R, Blaufox MD: Effect of hemodialysis on left ventricular function in uremic cardiomyopathy. N Engl J Med 303: 523, 1980

    Article  PubMed  CAS  Google Scholar 

  152. Verbeelen D, Bossuyt A: Effect of hemodialysis on left ventricular function in uremic cardiomyopathy: Engl J Med 303: 523, 1980

    Article  CAS  Google Scholar 

  153. Edson J, Avram MM, Gan A, Edson JN: Cardiac arrhythmias in hemodialysis patients. Proc Clin Dial Transpl Forum 7: 83, 1977

    Google Scholar 

  154. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17: 811, 1980

    Article  PubMed  CAS  Google Scholar 

  155. Lavelle KJ, Dentino MM: Surgical treatment of infective endocarditis in hemodialysis patients. Clin Nephrol 9: 6, 1978

    PubMed  CAS  Google Scholar 

  156. Tobin M, Montes M, Mookerjee BK: Endocarditis in hemodialysis patients with systemic disease. J Dial 2: 75, 1978.

    PubMed  CAS  Google Scholar 

  157. Gregoratos G, Karliner JS: Infective endocarditis. Diagnosis and management. Med Clin North Am 63: 173, 1979.

    PubMed  CAS  Google Scholar 

  158. Leonard A, Raij L, Shapiro FL: Bacterial endocarditis in regularly dialyzed patients. Kidney Int 4: 407, 1973

    Article  PubMed  CAS  Google Scholar 

  159. Bolton CF: Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 7: 89, 1980.

    PubMed  CAS  Google Scholar 

  160. Jebsen RH, Tenckhoff H, Honet JC: Natural history of uremic polyneuropathy and effects on dialysis. N Engl J Med 277: 327, 1967

    Article  PubMed  CAS  Google Scholar 

  161. Nielsen VK: The peripheral nerve function in chronic renal failure VII. Longitudinal course during terminal renal failure and regular haemodialysis. Acta Med Scand 195: 155, 1974

    Article  PubMed  CAS  Google Scholar 

  162. Kjellstrand CM, Petersen RJ, Evans RL, Shideman JR, von Hartitzsch B, Buselmeier TJ: Considerations of the middle molecule hypothesis II: neuropathy in the nephrectomized patients. Trans Am Soc Artic Intern Organs 19: 325, 1973

    CAS  Google Scholar 

  163. Dyck PJ, Johnson WJ, Lambert ER, Bushek W, Pollock M: Detection and evaluation of uremic peripheral neuropathy in patients on hemodialysis. Kidney Int 1 (Suppl 2):S 201, 1975

    Google Scholar 

  164. Tenckhoff H, Jebsen RH, Honet JC: The effect of long term dialysis treatment on the course of uremic neuropathy. Trans Am Soc Artiflnt Organs 13: 58, 1967

    Google Scholar 

  165. Tyler HM: Neuropathy in uremic patients on dialysis. New Engl J Med 292: 1075, 1975

    Article  PubMed  CAS  Google Scholar 

  166. Thomas PK: Peripheral neuropathy in dialysis patients. Int J Artif Organs 3: 6, 1980

    PubMed  CAS  Google Scholar 

  167. Daniel CR, Bower JD, Pearson JE, Holbert RD: Vibrometry and uremic peripheral neuropathy. South Med J 70: 1311, 1977

    Article  PubMed  Google Scholar 

  168. Avram MM, Feinfeld DA, Huatuco AH: Search for the uremic toxin. Decreased motornerve conduction velocity and elevated parathyroid hormone in uremia. N Engl J Med 298: 1000, 1978

    Article  PubMed  CAS  Google Scholar 

  169. Man NK, Cueille G, Zingraff J, Boudet J, Sausse A, Funck-Brentano JL: Uremic neurotoxin in the middle molecular weight range. Artif Organs 4: 116, 1979

    Article  Google Scholar 

  170. Otsubo O, Kuzuhara K, Simada Y, Yamauchi Y, Takahashi I, Yamada Y, Otsubo K, Inou T: Treatment of uraemic peripheral neuritis by direct haemoperfusion with activated charcoal. Proc Eur Dial Transpl Assoc 16: 731, 1979

    CAS  Google Scholar 

  171. Bolton CF, Noltzon MA, Boltzon RB: Effects of renal transplantation on uremic neuropathy. N Engl J Med 284: 1170, 1971

    Article  PubMed  CAS  Google Scholar 

  172. Oh ST, Clement RS, Lee YW, Diethelm AG: Rapid improvement in nerve conduction velocity following renal transplantation. Ann Neurol 4: 369, 1978

    Article  PubMed  CAS  Google Scholar 

  173. Jain VK, Cestero RV, Baum J: Carpal tunnel syndrome in patients undergoing maintenance hemodialysis. JAMA 242: 2868, 1979

    Article  PubMed  CAS  Google Scholar 

  174. Kenzora JE: Dialysis carpal tunnel syndrome: Orthopedics 1: 195, 1978

    PubMed  CAS  Google Scholar 

  175. Harding AE, LeFanu J: Carpal tunnel syndrome, related to antebrachial Cimino-Brescia fistula. J Neurol Neurosurg Psychiatry 40: 511, 1977

    Article  PubMed  CAS  Google Scholar 

  176. Brautbar N, Kleeman CR: Disordered divalent ion metabolism in kidney failure. Adv Nephrol 8: 179, 1979

    CAS  Google Scholar 

  177. Alvarez-Ude F, Feest TG, Ward MK, Pierides AM, Ellis HA, Peart M, Simpson W, Weightman D, Kerr DNS: Hemodialysis bone disease: Correlation between clinical, histologic, and other findings. Kidney Int 14: 68, 1978

    Article  PubMed  CAS  Google Scholar 

  178. Goldsmith RS, Furszyfer J, Johnson WJ, Fournier AE, Arnaud CD: Control of secondary hyperparathyroidism during long term hemodialysis. Am J Med 50: 692, 1971

    Article  PubMed  CAS  Google Scholar 

  179. Slatopolsky E, Rutherford WE, Hoffstein PS, Elkan IO, Bütcher HR, Bricker NS: Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Kidney Int 1: 38, 1972

    Article  PubMed  CAS  Google Scholar 

  180. Baker LR, Muir JW, Cattell WR, Tucker KA, Sharman VL, Goodwin FJ, Marsh FP, Hately W, Morgan AG, DeSäintonge DM: Use of l,25(OH)2-Vitamin D3 in prevention of renal osteodystrophy: preliminary observations. Contrib Nephrol 18: 147, 1980

    PubMed  CAS  Google Scholar 

  181. Berl T, Berns AS, Hufer WE, Hammiii K, Alfrey AC, Arnaud CD, Schrier RW: 1,25 Dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study. Ann Intern Med 88: 774, 1978

    PubMed  CAS  Google Scholar 

  182. Coburn JW, Koppel MH, Brickman AS, Massry SG: Studies on intestinal absorption of calcium in patients with renal failure. Kidney Int 3: 264, 1973

    Article  PubMed  CAS  Google Scholar 

  183. Oettinger CW, Merrill R, Blanton T, Briggs W: Reduced calcium absorption after nephrectomy in uremic patients. New Engl J Med 291: 458, 1974

    Article  PubMed  CAS  Google Scholar 

  184. Llach F, Massry SG, Koffler A, Malluche HH, Singi FR, Brickman AS, Kurokawa K: Secondary hyperparathyroid-ism in early renal failure. Role of phosphate retention. Kidney Int 12: 459, 1977

    Google Scholar 

  185. Sundaram M, Joyce PF, Shields JB, Riaz MA, Sagar S: Terminal phalangeal tufts: earliest site of renal osteodystrophy findings in hemodialysis patients. Am J Roent 133: 25, 1979

    CAS  Google Scholar 

  186. Guerra LE, Amato JA, Maher JF: Inconsistency in radiographic evaluation of progressive renal osteodystrophy Clin Nephrol 11: 307, 1979.

    PubMed  CAS  Google Scholar 

  187. Olgaard K, Madsen S, Heerfordt J, Hammer M, Jensen H: Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure. Clin Nephrol 12: 273, 1979

    PubMed  CAS  Google Scholar 

  188. Duursma SA, Visser WJ, Mees EJD, Njio L: Serum calcium, phosphate and alkaline phosphatase and morphometric bone examination in 30 patients with renal insufficiency. Calcif Tissue Res 16: 129, 1974

    Article  PubMed  CAS  Google Scholar 

  189. Varghese Z, Farrington K, Moorhead JF: Renal osteodystrophy. Dietary influences and management. Proc Nutr Soc 38: 337, 1979

    Article  PubMed  CAS  Google Scholar 

  190. Fischer JA, Binswanger U: 1, 25-dihydroxycholecalciferol in dialysed patients with clinically asymptomatic renal osteodystrophy A controlled study. Contrib Nephrol 18: 82, 1980

    PubMed  CAS  Google Scholar 

  191. Brickman AS, Sherrard DJ, Jowsey J, Singer FR, Baylink DJ, Maloney N, Massry SG, Norman AW, Coburn JW: 1,25 dihydroxycholecalciferol: Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. Arch Intern Med 134: 883, 1974

    Article  PubMed  CAS  Google Scholar 

  192. Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Fernere C, Bedrossian J, DeLuca HF: Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalcife rol in the treatment of bone mineralization. Greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int 15: 196, 1979

    Article  PubMed  CAS  Google Scholar 

  193. Manji T, Kobayashi K: Effect of laOHD3 on bone mineral content in the forearm of chronic hemodialyzed patients. Contrib Nephrol 22: 39, 1980

    PubMed  CAS  Google Scholar 

  194. Bordier P, Zingraff J, Guéris J, Jungers P, Marie P, Péchet M, Rasmussen H: The effect of 1 a (OH) D3 and 1 a, 25(OH2) D3 on the bone in patients with renal osteodystrophy. Am J Med 64: 101, 1978

    Article  PubMed  CAS  Google Scholar 

  195. DeLuca HF: Vitamin D endocrinology. Ann Intern Med 85: 367, 1976

    PubMed  CAS  Google Scholar 

  196. Swanson MR, Biggers JA, Remmers AR Jr, Sarles HE, Nelson RM, Fish JC: Results of parathyroidectomy for autonomous hyperparathyroidism. Arch Intern Med 139: 989, 1979

    Article  PubMed  CAS  Google Scholar 

  197. Quinton W, Dillard D, Scribner BH: Cannulation of blood vessels for prolonged dialysis. Trans Am Soc Artie Int Organs 6: 104, 1960

    CAS  Google Scholar 

  198. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Eng J Med 290: 697, 1974

    Article  CAS  Google Scholar 

  199. Lundin AP, Adler AJ, Feinroth MV, Berlyne GM, Friedman EA: Maintenance hemodialysis survival beyond the first decade. JAMA 244: 38, 1980

    Article  PubMed  Google Scholar 

  200. Lundin AP, Stein RA, Frank F, Berlyne GM, Krasnow N, Friedman EA: Cardiovascular status in long term hemodialysis patients. An exercise and echocardiographic study. Nephron 28: 234, 1981

    Article  Google Scholar 

  201. Roseman PM, Leu ML, Sacerdote A, Lundin AP, Delano BG, Friedman EA, Wallace EZ: Pituitary gland reserve in patients on long term hemodialysis. Clin Res 28: 266A, 1980

    Google Scholar 

  202. Avram MM: Survival after 10 years of dialysis and prevention of renal disease. In: Proceedings edited by Avram MM, New York, London, Plenum Med Book Co, 1982

    Google Scholar 

  203. Becker EL: Finite resources and medical triage. Am J Med 6: 549, 1979

    Article  Google Scholar 

  204. Rathaus M, Bernheim JL: Are your elderly patients good candidates for dialysis? Geriatrics 33: 56, 1978

    PubMed  CAS  Google Scholar 

  205. Chester AC, Rakowski TA, Argy WP Jr, Giacalone A, Schreiner GE: Hemodialysis in the eight and ninth decades of life. Arch Intern Med 139: 1001, 1979

    Article  PubMed  CAS  Google Scholar 

  206. Ghentons WN, Bailery GL, Zschaeck D, Hampers CL, Merrill JP: Long term hemodialysis in the elderly. Trans Am Soc Artif Intern Organs 17: 125, 1971

    Google Scholar 

  207. Rao TKS, Nathanson G, Avram M, Manis T, Kountz SL, Friedman EA: Improved survival in older, sicker patients begun on maintenance hemodialysis. Proc Clin Dial Transpl Forum 6: 62, 1976

    CAS  Google Scholar 

  208. Jacobs C, Brummer FP, Chantier C, Donckerwolcke RA, Gurland HJ, Hathway RA, Seiwood NH, Wing AJ: Combined report of regular dialysis and transplantation in Europe VII. 916—Proc Eur Dial Transpl Assoc 14: 3, 1977.

    CAS  Google Scholar 

  209. Burke J, Francos G, Moore L: Accelerated atherosclerosis in chronic dialysis patients. Another Look. Nephron 21: 181, 1978

    Article  PubMed  Google Scholar 

  210. Rostand SG: Ischemic heart disease in patients undergoing maintenance hemodialysis. Kidney Int 16: 600, 1979

    Article  PubMed  CAS  Google Scholar 

  211. Vaziri ND, Prakash R: Echocardiographic evaluation of the effect of hemodialysis on cardiac size and function in end stage renal disease. Am J Med Sci 278: 201, 1979

    Article  PubMed  CAS  Google Scholar 

  212. Scharf S, Wexler J, Longnecker RE, Blaufox MD: Cardiovascular disease in patients on chronic hemodialysis therapy. Prog Cardiovasc Dis 22: 343, 1980

    Article  PubMed  CAS  Google Scholar 

  213. Chawla R, Gailiunas P Jr, Lazarus JM, Gottlieb MN, Lowrie EG, Collings JJ, Merrill JP: Cardiopulmonary by-pass surgery in chronic hemodialysis and transplant patients. Trans Am Soc Artif Intern Organs 23: 694, 1977

    PubMed  CAS  Google Scholar 

  214. Byrd LH, Sullivan JF: Successful coronary artery bypass in a hemodialysis patient. J Dial 2: 33, 1978

    PubMed  CAS  Google Scholar 

  215. Crawford FA, Selby JH, Bewer JP, Lehan P: Coronary revascularization in patients maintained on hemodialysis. Circulation 56: 684, 1977

    PubMed  Google Scholar 

  216. Rao TKS, Hirsch S, Avram MM, Friedman EA: Prevalence of diabetic nephropathy in Brooklyn. In: Diabetic Renal-Retinal Syndrome edited by Friedman EA, L’Esperance FA. New York, Grune and Stratton, 1980, p 205

    Google Scholar 

  217. Comty CM, Kjellsen D, Shapiro FL: A reassessment of the prognosis of diabetic patients treated by chronic he-modialysis. Trans Am Soc Artif Intern Organs 22: 404, 1976

    PubMed  CAS  Google Scholar 

  218. Arieff AI: Kidney, water, and electrolyte metabolism in diabetes mellitus. In The Kidney, edited by Brenner BM, Rector FC, Philadelphia PA, WB Saunders Co, 1976, p 1268

    Google Scholar 

  219. Avram MM, Slater PA, Fein PA, Altman E: Comparative survival of 673 patients with chronic uremia treated with renal transplantation and maintenance hemodialysis. Trans Am Soc Artif Intern Organs 25: 391, 1979

    PubMed  CAS  Google Scholar 

  220. Friedman EA, Rubin JA: Dialysis and transplant of diabetics in the U.S. Nephron 18: 309, 1977

    Article  PubMed  Google Scholar 

  221. Blagg CR: Visual and vascular problems in dialyzed diabetic patients. Kidney Int 6 (Suppl 1): S27, 1974

    Google Scholar 

  222. Rassissieh SD, Yen MC, Lazarus JM, Lowrie EG, Goldstein HH, Takacs FJ, Hampers CL, Merrill JP: Hemodialysis-related problems in patients with diabetes mellitus. Kidney Int 6 (Suppl 1):S 100, 1974

    Google Scholar 

  223. Goldstein DA, Massry SG: Diabetic nephropathy: Clinical course and effect of hemodialysis. Nephron 20: 286, 1978.

    Article  PubMed  CAS  Google Scholar 

  224. Butt KMH, Ortega-Gayton M, Shirani K, Hong JH, Adamson RJ, Manis T, Friedman EA. Angioaccess in uremic diabetics. In Diabetic-Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune amp; Stratton, 1980, p 209

    Google Scholar 

  225. Potter DJ: Death as a result of hyperglycemia without ketosis. A complication of hemodialysis. Ann Intern Med 64: 399, 1966

    PubMed  CAS  Google Scholar 

  226. Ma KW, Masler DS, Brown DC: Hemodialysis in diabetic patients with chronic renal failure. Ann Intern Med 83: 215, 1975

    PubMed  CAS  Google Scholar 

  227. Pitkanen E, Koivula T: Continuous blood glucose monitoring and characteristics of diabetes in patients on maintenance hemodialysis treatment. Scand J Urol Nephrol 12: 309, 1979

    Article  Google Scholar 

  228. Levitz CS, Hirsch S, Ross JM, Butt KMH, Friedman EA: Lack of blood glucose control in hemodialyzed and renal transplantation diabetics. Trans Am Soc Artif Intern Organ 26: 362, 1980

    CAS  Google Scholar 

  229. Watkins PJ, Parsons V, Bewick M: The prognosis and management of diabetic nephropathy. Clin Nephrol 7: 243, 1977

    PubMed  CAS  Google Scholar 

  230. Jones R, Poston L, Hinestrosa H, Parsons V, Williams R: Weight gain between dialyses in diabetics: Possible significance of raised intracellular sodium content. Br Med J 280: 153, 1980

    Article  PubMed  CAS  Google Scholar 

  231. Burn J, Gill GV, Flear CT: Weight gain between dialysis in diabetics. Br Med J 280: 643, 1980

    Article  PubMed  CAS  Google Scholar 

  232. Lazarus JM, Kjellstrand CM: Dialysis: medical aspects. In: The Kidney edited by Brenner BM, Rector FC, WB Saunders Co, Philadelphia PA 1981, p 2521

    Google Scholar 

  233. Davis M, Comty C, Shapiro F: Dietary management of patients with diabetes treated by hemodialysis. J Am Diet Assoc 75: 265, 1979

    PubMed  CAS  Google Scholar 

  234. Gral T, Schroth P, Rosen V, Sellers A, Maxwell MH: Is chronic hemodialysis indicated in the treatment of terminal lupus nephritis? Abstracts Am Soc Nephrol 4: 31, 1970

    Google Scholar 

  235. Coplon NS, Siegel RC, Fried JF: Hemodialysis in end stage lupus nephritis. Abstracts Am Soc Artif Intern Organs 2: 14, 1973

    Google Scholar 

  236. Fries JF, Powers R, Kempson R: Late stage lupus nephropathy. J Rheumatol 1: 166, 1974

    PubMed  CAS  Google Scholar 

  237. Friedman EA: Lupus-nephritis. What to do until data arrives? Nephron 19: 190, 1978

    Article  Google Scholar 

  238. Maxey RW, Rao TKS, Ginzler E, Butt KMH, Kountz EA, Friedman FA: Course of treated uremia due to systemic lupus erythematosus. Abstracts Am Soc Artif Intern Organs 6: 56, 1977

    Google Scholar 

  239. Delano BG, Feinroth MV, Feinroth M, Friedman EA: Home and medical center hemodialysis: Dollar compari-son and payback period. JAMA 246: 230, 1981

    Article  PubMed  CAS  Google Scholar 

  240. McKinney TD, McAllister CJ, Stone WJ, Johnson HK, Ginn HE: Hemodialysis and renal transplantation in progressive systemic sclerosis: report of two cases. Clin Nephrol 12: 178, 1979

    PubMed  CAS  Google Scholar 

  241. Cooper WL, Winer RL, Mira Hadi KS, Gorman JT: Hemodialysis for progressive systemic sclerosis with renal failure. Abstracts Am Soc Nephrol 9: 29, 1976

    Google Scholar 

  242. Rao TKS: Hemodialysis and transplantation in systemic disease: the facts. In: Strategy for Renal Failure, edited by Friedman EA, New York, John Wiley amp; Co, 1978, p 321

    Google Scholar 

  243. Javier P, Dumler F, Levin NW: Renal scleroderma: Comparison of different modalities of treatment. South Med J 73: 657, 1980

    Article  PubMed  CAS  Google Scholar 

  244. Leroy ED, Fleischmann RM: The management of renal scleroderma: Experience with dialysis, nephrectomy and transplantation Am J Med 64: 974, 1978

    Article  PubMed  CAS  Google Scholar 

  245. Simon NM, Graham MB, Kyser FA, Gashti EN: Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature. Am J Med 67: 533, 1979

    Article  PubMed  CAS  Google Scholar 

  246. Barker DJ, Farr MJ: Resolution of cutaneous manifestations of systemic sclerosis after haemodialysis. Br Med J 1: 501, 1976

    Article  PubMed  CAS  Google Scholar 

  247. Cheigh JS, Kim SJ: Scleroderma kidney disease: A therapeutic approach with nephrectomy and hemodialysis. J Dial 1: 349, 1977

    PubMed  CAS  Google Scholar 

  248. Lam M, Ricanati ES, Khan MR, Kushner I: Reversal of severe renal failure in systemic sclerosis. Ann Intern Med 89: 642, 1978

    PubMed  CAS  Google Scholar 

  249. Dabir-Vaziri N, Goldman R, Schultze RG: Dialysis in myeloma kidney disease Abstracts Am Soc Artif Int Organs 3: 15, 1974

    Google Scholar 

  250. Leech SH, Polesky HF, Shapiro FL: Chronic hemodialysis in myelomatosis. Ann Intern Med 77: 239, 1972

    PubMed  CAS  Google Scholar 

  251. Johnson WJ, Kyle RA, Dahlberg PJ: Dialysis in the treatment of multiple myeloma. Mayo Clin Proc 55: 65, 1980

    PubMed  CAS  Google Scholar 

  252. Avram MM: Survival in uremia due to systemic diseases. Kidney Int (Suppl 8) S 55, 1978

    Google Scholar 

  253. Randall RE, Williamson WC, Mullinax F, Tung MF, Still JS: Manifestations of systemic light chain deposition. Am J Med 60: 293, 1976

    Article  PubMed  CAS  Google Scholar 

  254. Ari JB, Zlotnik M, Oren A, Berlyne GM: Dialysis in renal failure caused by amyloidosis of familial Mediterranean fever. Arch Intern Med 136: 449, 1976

    Article  PubMed  CAS  Google Scholar 

  255. Rubinger D, Friedlaender MM, Popovtzer MM: Amelioration of familial Mediterranean fever during hemodialysis. N Engl J Med 301: 142, 1979

    Article  PubMed  CAS  Google Scholar 

  256. Anonymous: Treatment of renal amyloidosis. Editorial. Lancet 1: 1062, 1980

    Google Scholar 

  257. Shapiro W, Chou SY, Porush TC: Nephrectomy for intractable proteinuria secondary to severe nephrotic syndrome. Abstracts Am Soc Nephrol 8: 24, 1975

    Google Scholar 

  258. Avram MM, Lipner H, Gan AC: Medical nephrectomy. The use of metallic salts for the control of massive proteinuria in the nephrotic syndrome. Trans Am Soc Artif Intern Organs 22: 431, 1976

    PubMed  CAS  Google Scholar 

  259. Stone WJ, Latos DL, Lankford PG, Baker AS: Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure and factor X deficiency. South Med J 71: 764, 1978

    Article  PubMed  CAS  Google Scholar 

  260. Toussaint C, Dupont E, Vanherweghem JL, Cappel R, DeRoy G, Vereerstraeten P, Kinnaert P, Thiry L, Van Geertruyden J: Liver disease in patients undergoing hemodialysis and kidney transplantation. Adv Nephrol 8: 269, 1979

    CAS  Google Scholar 

  261. Wilkinson SP, Weston MJ, Parsons V, Williams R: Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 8: 287, 1977

    PubMed  CAS  Google Scholar 

  262. Adler AJ, Feldman J, Friedman EA, Berlyne GM: Use of extracorporeal ascites dialysis in combined hepatic and renal failure. Nephron 30: 31, 1982

    Article  PubMed  CAS  Google Scholar 

  263. Gotloib L, Servadis C: Ascites in patients undergoing maintenance hemodialysis. Am J Med 61: 65, 1976

    Article  Google Scholar 

  264. Feingold LN, Gutman RA, Walsh FX, Gunnels JC Control of cachexia and ascites in hemodialysis patients by bilateral nephrectomy. Arch Intern Med 134: 889, 1974

    Article  Google Scholar 

  265. Wang F, Pillary VKG, Ing TS, Armbruster KFW, Rosenberg JC: Ascites in patients treated with maintenance hemodialysis. Nephron 12: 105, 1974

    Article  PubMed  CAS  Google Scholar 

  266. Singh S, Mitra S, Berman L: Ascites in patients on maintenance hemodialysis. Nephron 12: 114, 1974

    Article  PubMed  CAS  Google Scholar 

  267. Arismendi GS, Izard MW, Hampton WR, Maher JF: The clinical spectrum of ascites associated with maintenance dialysis. Am J Med 60: 46, 1976

    Article  PubMed  CAS  Google Scholar 

  268. Craig R, Sparberg M, Ivanovich P, Rich L, Doidal E: Nephrogenic ascites. Arch Intern Med 134: 276, 1974

    Article  PubMed  CAS  Google Scholar 

  269. Eknoyan G, Dichoso C, Hyde S, Yium J: 4Overflow ascites’ — the safety valve of the volume-expanded patient on dialysis. Proc Clin Dial Transpl Forum 3: 156, 1973

    CAS  Google Scholar 

  270. Buselmeier TJ, Simmons RL, Duncan DA: Local steroid treatment of intractable ascites in dialysis patients. Proc Clin Dial Transpl Forum 5: 9, 1975

    CAS  Google Scholar 

  271. Rao TKS, Nicastri AD, Friedman EA: Natural history of heroin associated nephropathy. N Engl J Med 290: 19, 1974

    Article  PubMed  CAS  Google Scholar 

  272. Friedman EA, Manis T, Delano BG: Response of psychotic and sociopathic patients to maintenance hemodialysis. Abstracts Am Soc Artif Intern Organs 2: 22, 1973

    Google Scholar 

  273. Friedman EA, Rao TKS, Sprung GL, Smith A, Manis T, Bellervue R, Butt KMH, Lenere RD, Holden DM: Urem-ia in sickle cell anemia treated by maintenance hemodialysis. N Engl J Med 291: 431, 1974

    Article  PubMed  CAS  Google Scholar 

  274. Gold DD: Hemodialysis and transfusions for uremic patients with sickle cell disease. N Engl J Med 291: 1361, 1974

    Article  PubMed  Google Scholar 

  275. Elberg AJ, Baker R, Koch K, Gorman H, Wenger AJ, Strauss J: Transfusion requirements in patients with sickle cell disease on hemodialysis. N Engl J Med 294: 444, 1976

    PubMed  CAS  Google Scholar 

  276. Pote HH Jr, Lyons H, Schwartz AB: Hemodialysis in sickle cell disease — 24 months experience. Abstracts Am Soc Artif Intern Organs 4: 51, 1975

    Google Scholar 

  277. Butt KMH, Kountz SL: A new vascular access for hemodialysis, the arterial jump graft. Surgery 79: 476, 1976

    PubMed  CAS  Google Scholar 

  278. Manis T, Friedman EA: Sickle hemoglobinopathy and the kidney. Contrib Nephrol 7: 211, 1977

    PubMed  CAS  Google Scholar 

  279. Nemoto R, Sugiyama Y, Kuwahara M, Kato T, Tsuchida S: Successful delivery of a patient on hemodialysis for acute renal failure: a case report and review of the literature. J Urol 118: 673, 1977

    PubMed  CAS  Google Scholar 

  280. Naik RB, Clark AC, Warren DJ: Acute proliferative glomerulonephritis with crescents and renal failure in pregnancy successfully managed by intermittent haemodialysis. Case Report. Br J Obstet Gynaecol 86: 819, 1979

    Article  PubMed  CAS  Google Scholar 

  281. Goodwin NJ, Valenti C, Hall JE, Friedman EA: Effect of uremia and chronic hemodialysis on the reproductive cycle. Am J Obstet Gynecol 100: 528, 1968

    PubMed  CAS  Google Scholar 

  282. Wing AJ, Brunner FP, Brynger H, Chantler C, Donckerwoloke RA, Gurland HJ, Hathway RA, Jacobs C, Selwood NH: Combined report on regular dialysis and transplantation in Europe. VIII 1977. Proc Eur Dial Transpl Assoc 15: 2, 1978

    CAS  Google Scholar 

  283. Sheriff MH, Hardman M, Lamont CA, Shepherd R, Warren DJ: Successful pregnancy in a 44-year-old haemodialysis patient. Br J Obstet Gynaecol 85: 386, 1978

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Delano, B.G. (1983). Regular Dialysis Treatment (RDT). In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6768-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6768-7_20

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-89838-770-4

  • Online ISBN: 978-94-009-6768-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics